MMED
HoldFallen FavouriteMiniMed Group, Inc. · Healthcare · United States · $5.7B · Avg Vol: $44M/d
Fallen Favourite: A good business that is expensive and falling. Wait for the price to catch up.
ABOUT MINIMED GROUP, INC.
Read
Minimed Group, Inc. is a healthcare company focused on the development and commercialization of medical products or services, likely within a specialized therapeutic area or medical device segment. The company aims to differentiate through innovation and targeted solutions that address specific patient needs. Its success hinges on clinical validation, regulatory approvals, and effective market penetration in a competitive healthcare landscape.
FINANCIAL SUMMARY (USD)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.2B | 2.5B | 2.7B | 3.1B | 11.4% | 3.2B | 3.6B | 3.9B | 12.2% |
| EPS | -0.34 | -0.40 | -0.76 | -1.30 | — | -1.12 | — | — | — |
| Shares | — | 280.8M | 280.8M | 280.8M | +0.0% | 281.3M | — | — | — |
| Debt | — | 8.0M | 11.0M | 145.0M | 325.7% | 59.0M | — | — | — |
| Equity | — | 3.4B | 3.3B | 3.6B | 2.3% | — | — | — | — |
| Op CF | -6.0M | 41.0M | 140.0M | -197.0M | 241.5% | -105.0M | — | — | — |
| Inv CF | -180.0M | -157.0M | -193.0M | -233.0M | — | — | — | — | — |
| Fin CF | 185.0M | 112.0M | 10.0M | 716.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MMED are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MMED | MiniMed Group, Inc.(you) | $5.7B | 40 | Hold |
| WRBY | Warby Parker Inc. | $3.1B | 34 | Sell |
| RGEN | Repligen Corporation | $9.9B | 50 | Hold |
| TFX | Teleflex Incorporated | $5.9B | 66 | Buy |
| ICUI | ICU Medical, Inc. | $4.4B | 63 | Hold |
| PLSE | Pulse Biosciences, Inc. | $3.4B | 22 | Sell |
| BLFS | BioLife Solutions, Inc. | $1.8B | 50 | Hold |
| AZTA | Azenta, Inc. | $1.4B | 46 | Hold |
| LMAT | LeMaitre Vascular, Inc. | $1.8B | 53 | Hold |
| XRAY | DENTSPLY SIRONA Inc. | $2.2B | 58 | Hold |
Peer medians: ROE -31.0% · P/E 25.1x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.